PATENT CLAIM ANALYSIS

Application Number: 16041416
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["514", "161000"]

Abstract:
Disclosed herein are methods of treating subjects suffering from estrogen receptor positive cancer of the brain by administering a selective estrogen receptor degrader (SERM). Also disclosed are methods of treating a cancer that is resistant to an estrogen receptor modulator by administering a SERM.

Claim (Index 18):
The method of  claim 17 , wherein the effective amount comprises a high dosage.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 95.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14512061', '15214187', '15129197', '15939218', '12269024']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7723705039561921
- 35 USC 102 Novelty (BERT): 0.5462385182259866
- Combined Prediction Score: 0.7497573053831715
- Mean Citation Score: 316.21264600000006
- Max Citation Score: 393.38837
- Similarity Product: 331.12561973615414

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test